Transdel Pharmaceuticals hires IRG as its AOR
News in Brief
LA JOLLA, CA: Transdel Pharmaceuticals named The Investor Relations Group its AOR, effective November 1. The New York-based firm is providing IR and PR services for the La Jolla, CA-based pharmaceutical company, which develops non-invasive, topical medications.
LA JOLLA, CA: Transdel Pharmaceuticals named The Investor Relations Group its AOR, effective November 1. The New York-based firm is providing IR and PR services for the La Jolla, CA-based pharmaceutical company, which develops non-invasive, topical medications.